A randomized trial of olanzapine versus palonosetron versus infused ondansetron for the treatment of breakthrough chemotherapy-induced nausea and vomiting in patients undergoing hematopoietic stem cell transplantation

被引：0
|
作者：
Midori Nakagaki
Michael Barras
Cameron Curley
Jason P. Butler
Glen A. Kennedy
机构：
[1] Royal Brisbane and Women’s Hospital,Pharmacy Department, Level 1 Ned Hanlon Building
[2] The University of Queensland,Bone Marrow Transplant Unit, Level 5 Joyce Tweddell Building
[3] Royal Brisbane and Women’s Hospital,undefined
来源：
Supportive Care in Cancer | 2017年 / 25卷
关键词：
Stem cell transplantation; Antiemetics; Ondansetron; Palonosetron; Olanzapine; Nausea and vomiting;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
下载
收藏
页码：607 / 613
页数：6
相关论文
共 50 条
  • [1] A randomized trial of olanzapine versus palonosetron versus infused ondansetron for the treatment of breakthrough chemotherapy-induced nausea and vomiting in patients undergoing hematopoietic stem cell transplantation
    Nakagaki, Midori
    Barras, Michael
    Curley, Cameron
    Butler, Jason P.
    Kennedy, Glen A.
    SUPPORTIVE CARE IN CANCER, 2017, 25 (02) : 607 - 613
  • [2] A Randomized Trial of Olanzapine and Palonosetron versus Infused Ondansetron for the Treatment of Chemotherapy Induced Nausea and Vomiting in Patients Undergoing Hematopoietic Stem Cell Transplantation
    Nakagaki, Midori
    Barras, Michael
    Curley, Cameron
    Butler, Jason P.
    Kennedy, Glen A.
    BLOOD, 2015, 126 (23)
  • [3] Palonosetron versus ondansetron in CINV (chemotherapy-induced nausea and vomiting)
    Vieira, S.
    Monroe, D.
    Sorita, R.
    Palomar, M.
    Librojo, M.
    Porin, L.
    Ng, J.
    Taylor, A.
    BONE MARROW TRANSPLANTATION, 2010, 45 : S370 - S370
  • [4] The Use of Olanzapine Versus Metoclopramide for the Treatment of Breakthrough Chemotherapy-Induced Nausea and Vomiting in Patients Receiving Highly Emetogenic Chemotherapy
    Navari, Rudolph
    Nagy, Cindy
    Gray, Sarah
    PSYCHO-ONCOLOGY, 2013, 22 : 31 - 31
  • [5] The use of olanzapine versus metoclopramide for the treatment of breakthrough chemotherapy-induced nausea and vomiting in patients receiving highly emetogenic chemotherapy
    Rudolph M. Navari
    Cindy K. Nagy
    Sarah E. Gray
    Supportive Care in Cancer, 2013, 21 : 1655 - 1663
  • [6] The use of olanzapine versus metoclopramide for the treatment of breakthrough chemotherapy-induced nausea and vomiting in patients receiving highly emetogenic chemotherapy
    Navari, Rudolph M.
    Nagy, Cindy K.
    Gray, Sarah E.
    SUPPORTIVE CARE IN CANCER, 2013, 21 (06) : 1655 - 1663
  • [7] ONDANSETRON VERSUS GRANISETRON IN THE PREVENTION OF CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING - RESULTS OF A PROSPECTIVE RANDOMIZED TRIAL
    GEBBIA, V
    CANNATA, G
    TESTA, A
    CURTO, G
    VALENZA, R
    CIPOLLA, C
    LATTERI, MA
    GEBBIA, N
    CANCER, 1994, 74 (07) : 1945 - 1952
  • [8] Palonosetron versus ondansetron as prophylaxis of chemotherapy-induced nausea and vomiting: a single-centre experience
    Tendas, A.
    Niscola, P.
    Cupelli, L.
    Trawinska, M. M.
    Abruzzese, E.
    Siniscalchi, A.
    Caravita, T.
    Scaramucci, L.
    Giovannini, M.
    Angelini, S.
    Perrotti, A. P.
    Dentamaro, T.
    Arcese, W.
    De Fabritiis, P.
    BONE MARROW TRANSPLANTATION, 2011, 46 : S174 - S174
  • [9] ONDANSETRON VERSUS GRANISETRON IN THE PREVENTION OF CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING
    FEDELE, P
    SPINA, M
    VALENTINI, M
    COLLINI, D
    LUCIA, C
    MANICONE, M
    TIRELLI, U
    CANCER, 1995, 76 (03) : 535 - 536
  • [10] Olanzapine versus aprepitant for the prevention of chemotherapy-induced nausea and vomiting (CINV): A randomized phase III trial
    Navari, R. M.
    Gray, S. E.
    Kerr, A. C.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
12345